-
2025-06-18
Gensci Showcases Women's Health and Immunology Innovations at BIO 2025Learn More
-
2025-06-18
NMPA Approves New Indication Clinical Trial of Megestrol Acetate Oral SuspensionLearn More
-
2025-06-17
Gensci Showcases BsADC Pipeline at 4th World ADC Asia SummitLearn More
-
2025-05-30
The FDA has Cleared the IND Application for GenSci128 for TP53 Y220C-Mutated Solid TumorsLearn More
-
2025-05-20
GenSci 2025 R&D Day: The Next Growth Frontier for a Billion-Dollar Growth Hormone LeaderLearn More
-
2025-03-21
Global R&D Milestone: Clinical Trial of GenSci120 Will Be Launched in the U.S.Learn More
-
2024-11-20
Chinese Monoclonal Anti-IL-1β Breakthrough: Acute Gout Arthritis Treatment Impresses at ACR 2024Learn More
-
2024-11-11
World ADC San Diego 2024: GenSci showcases two innovative pipeline programsLearn More
-
2024-11-07
Welcome to Visit Us at MEDICA 2024Learn More
-
2024-10-25
GenSci' s Inaugural R&D Day 2024: Innovation in Gene, Science in Actionsuccessfully concluded on October 17, 2024
Learn More
-
2024-07-26
Zhejiang University – GenSci Joint Research Center of Children’s Health establishedLearn More
-
2024-07-09
R&D Innovation Accelerator: Shanghai Children's Hospital and GenSci Ink Strategic Cooperation AgreementTwo Sides will Collaboratively Set Up a R&D Center
Learn More
-
2024-07-03
GenSci Invites you to join us in CPHI South East Asia 2024Join us at Booth H23 from July 10 to 12, 2024 to explore GenSci's flagship products.
Learn More
-
2024-06-28
China's First Aqueous Solution Progesterone Injection, Jin Sai Xin? ApprovedA further step towards GenSci's vision of becoming a global leader in Pediatric and Women's Health
Learn More
-
2024-06-05
Visit GenSci at CPhI China 2024At Booth W4E59, See you there!
Learn More
-
2025-03-07
Episil? Launched in China: A Breakthrough Solution for Oral MucositisLearn More
-
2025-02-20
GenSci Submits Another Blockbuster Product for Market ApprovalLearn More
-
2025-02-10
Clinical Trial Commencement of GenSci120 Injection ApprovedLearn More
-
2025-01-22
GenSci Showcases the Latest R&D Achievements at J.P. MorganLearn More
-
2025-01-17
NMPA Approves the PD-1 agonist GenSci120 for Clinical Trials CommencementLearn More
-
2025-01-06
Pediatric Golden Cough-Relief Granules Approved, a Superior Clinical Solution for Acute Cough in ChildrenLearn More